Brown Brothers Harriman & Co’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Hold
20
﹤0.01% 1409
2026
Q1
$9.6K Buy
+20
New +$10.2K ﹤0.01% 1367
2025
Q4
Sell
-400
Closed -$206K 1916
2025
Q3
$206K Hold
400
﹤0.01% 683
2025
Q2
$126K Buy
+400
New +$120K ﹤0.01% 738
2024
Q4
Sell
-8
Closed -$2.67K 1535
2024
Q3
$2.67K Buy
+8
New +$3.04K ﹤0.01% 1265

Other funds holding MEDP

Brown Brothers Harriman & Co's MEDP Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Medpace (MEDP) position steady in Q2 2026 at 20 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Brown Brothers Harriman & Co first reported a position in MEDP in Q3 2024 and has held it in 5 quarters since. The position peaked at $206K in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Brown Brothers Harriman & Co held 20 shares of Medpace worth $10.6K as of Q2 2026.
  • Brown Brothers Harriman & Co left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1409 holding.
  • Brown Brothers Harriman & Co first reported a position in Medpace in Q3 2024 and has held it in 5 quarters since.
  • Brown Brothers Harriman & Co's Medpace position peaked at $206K in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.